Palladium-based nanomaterials for cancer imaging and therapy

In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical properties, excellent biocompatibility and high stability in physiological environment. Compared with other intensively studied noble nanomaterials,...

Full description

Saved in:
Bibliographic Details
Published inTheranostics Vol. 10; no. 22; pp. 10057 - 10074
Main Authors Liu, Yongchun, Li, Jingchao, Chen, Mei, Chen, Xiaolan, Zheng, Nanfeng
Format Journal Article
LanguageEnglish
Published Australia Ivyspring International Publisher Pty Ltd 01.01.2020
Ivyspring International Publisher
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical properties, excellent biocompatibility and high stability in physiological environment. Compared with other intensively studied noble nanomaterials, such as gold (Au) and silver (Ag) nanomaterials, research on Pd-based nanomaterials started late, but the distinctive features, such as high photothermal conversion efficiency and high photothermal stability, have made them getting great attention in the field of nanomedicine. The goal of this review is to provide a comprehensive and critical perspective on the recent progress of Pd-based nanomaterials as imaging contrast agents and therapeutic agents. The imaging section focuses on applications in photoacoustic (PA) imaging, single-photon emission computed tomography (SPECT) imaging, computed tomography (CT) imaging and magnetic resonance (MR) imaging. For treatment of cancer, single photothermal therapy (PTT) and PTT combined with other therapeutic modalities will be discussed. Finally, the safety concerns, forthcoming challenges and perspective of Pd-based nanomaterials on biomedical applications will be presented.
AbstractList In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical properties, excellent biocompatibility and high stability in physiological environment. Compared with other intensively studied noble nanomaterials, such as gold (Au) and silver (Ag) nanomaterials, research on Pd-based nanomaterials started late, but the distinctive features, such as high photothermal conversion efficiency and high photothermal stability, have made them getting great attention in the field of nanomedicine. The goal of this review is to provide a comprehensive and critical perspective on the recent progress of Pd-based nanomaterials as imaging contrast agents and therapeutic agents. The imaging section focuses on applications in photoacoustic (PA) imaging, single-photon emission computed tomography (SPECT) imaging, computed tomography (CT) imaging and magnetic resonance (MR) imaging. For treatment of cancer, single photothermal therapy (PTT) and PTT combined with other therapeutic modalities will be discussed. Finally, the safety concerns, forthcoming challenges and perspective of Pd-based nanomaterials on biomedical applications will be presented.
In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical properties, excellent biocompatibility and high stability in physiological environment. Compared with other intensively studied noble nanomaterials, such as gold (Au) and silver (Ag) nanomaterials, research on Pd-based nanomaterials started late, but the distinctive features, such as high photothermal conversion efficiency and high photothermal stability, have made them getting great attention in the field of nanomedicine. The goal of this review is to provide a comprehensive and critical perspective on the recent progress of Pd-based nanomaterials as imaging contrast agents and therapeutic agents. The imaging section focuses on applications in photoacoustic (PA) imaging, single-photon emission computed tomography (SPECT) imaging, computed tomography (CT) imaging and magnetic resonance (MR) imaging. For treatment of cancer, single photothermal therapy (PTT) and PTT combined with other therapeutic modalities will be discussed. Finally, the safety concerns, forthcoming challenges and perspective of Pd-based nanomaterials on biomedical applications will be presented.In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical properties, excellent biocompatibility and high stability in physiological environment. Compared with other intensively studied noble nanomaterials, such as gold (Au) and silver (Ag) nanomaterials, research on Pd-based nanomaterials started late, but the distinctive features, such as high photothermal conversion efficiency and high photothermal stability, have made them getting great attention in the field of nanomedicine. The goal of this review is to provide a comprehensive and critical perspective on the recent progress of Pd-based nanomaterials as imaging contrast agents and therapeutic agents. The imaging section focuses on applications in photoacoustic (PA) imaging, single-photon emission computed tomography (SPECT) imaging, computed tomography (CT) imaging and magnetic resonance (MR) imaging. For treatment of cancer, single photothermal therapy (PTT) and PTT combined with other therapeutic modalities will be discussed. Finally, the safety concerns, forthcoming challenges and perspective of Pd-based nanomaterials on biomedical applications will be presented.
Author Li, Jingchao
Liu, Yongchun
Zheng, Nanfeng
Chen, Xiaolan
Chen, Mei
AuthorAffiliation 2 Department of Chemistry, Xiamen University, Xiamen, China
1 College of Materials Science and Engineering, Hunan University, Changsha, China
AuthorAffiliation_xml – name: 2 Department of Chemistry, Xiamen University, Xiamen, China
– name: 1 College of Materials Science and Engineering, Hunan University, Changsha, China
Author_xml – sequence: 1
  givenname: Yongchun
  surname: Liu
  fullname: Liu, Yongchun
– sequence: 2
  givenname: Jingchao
  surname: Li
  fullname: Li, Jingchao
– sequence: 3
  givenname: Mei
  surname: Chen
  fullname: Chen, Mei
– sequence: 4
  givenname: Xiaolan
  surname: Chen
  fullname: Chen, Xiaolan
– sequence: 5
  givenname: Nanfeng
  surname: Zheng
  fullname: Zheng, Nanfeng
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32929334$$D View this record in MEDLINE/PubMed
BookMark eNptkV9L5DAUxcOirDrrix9ACr4sQt0kvWkSEGER_4GwPrjPIU3TmUibjEkrzLc3o6OomJcE7u8czsndQ1s-eIvQAcEnnDD8Z1z4cAJMSvwD7RJRiZLXgLc-vHfQfkoPOB_AVBL5E-1UVFJZVbCLTu903-vWTUPZ6GTbwmsfBj3a6HSfii7EwmhvbCzcoOfOzwvt22Jc2KiXq19ou8uU3d_cM_T_8uL-_Lq8_Xd1c_73tjTA6VgC7VqoWwBN6pYZwqQ1uObEms4YQXBjgRoOwLBoMddSsyYrLM9qDqYh1Qydvfoup2awrbF-jLpXy5gzxZUK2qnPE-8Wah6eFAdBAIts8HtjEMPjZNOoBpeMzc29DVNSFIAKEDWrM3r0BX0IU_S5nqJMCgpMiHWiw4-J3qO8fWwGjl8BE0NK0XbvCMFqvTi1Xpx6WVyG8RfYuFGPLqzbuP47yTNBX5uk
CitedBy_id crossref_primary_10_3390_ijms241411442
crossref_primary_10_1007_s10876_024_02634_9
crossref_primary_10_1016_j_cclet_2021_12_057
crossref_primary_10_1021_acsanm_4c06257
crossref_primary_10_1021_acsomega_3c10324
crossref_primary_10_3390_catal13101343
crossref_primary_10_1007_s12649_024_02882_w
crossref_primary_10_1002_adhm_202500260
crossref_primary_10_1016_j_addr_2022_114506
crossref_primary_10_2147_IJN_S444471
crossref_primary_10_1016_j_tice_2023_102087
crossref_primary_10_34133_2021_9816594
crossref_primary_10_3390_ijms252413555
crossref_primary_10_1186_s12943_023_01784_0
crossref_primary_10_1039_D2NA00897A
crossref_primary_10_1016_j_bioadv_2025_214236
crossref_primary_10_1021_acsami_4c03530
crossref_primary_10_1039_D2SC00460G
crossref_primary_10_34133_bmr_0158
crossref_primary_10_3390_jnt4020008
crossref_primary_10_1002_smll_202005499
crossref_primary_10_1016_j_mtchem_2020_100402
crossref_primary_10_1002_anbr_202300107
crossref_primary_10_1007_s10904_023_02657_1
crossref_primary_10_3390_ijms22168736
crossref_primary_10_3390_ijms25094733
crossref_primary_10_1002_bit_28472
crossref_primary_10_1002_smll_202201179
crossref_primary_10_1021_acs_jpclett_3c03205
crossref_primary_10_2174_0113894501283669240123105250
crossref_primary_10_3762_bjnano_14_33
crossref_primary_10_1016_j_carbpol_2021_119021
crossref_primary_10_1016_j_ijpharm_2022_121489
crossref_primary_10_3390_pharmaceutics16091162
crossref_primary_10_1016_j_eurpolymj_2024_112835
crossref_primary_10_1039_D2CE00662F
crossref_primary_10_1039_D4BM00057A
crossref_primary_10_1186_s12943_024_02161_1
crossref_primary_10_1016_j_mtchem_2021_100694
crossref_primary_10_3389_fonc_2022_939365
crossref_primary_10_3390_hydrogen2040025
crossref_primary_10_1016_j_jphotochem_2022_114510
crossref_primary_10_1039_D1MA00069A
crossref_primary_10_1016_j_mri_2024_04_012
crossref_primary_10_1142_S1793292024300081
crossref_primary_10_1016_j_jinorgbio_2021_111429
crossref_primary_10_1002_slct_202103877
crossref_primary_10_1016_j_cej_2024_158682
crossref_primary_10_1186_s12951_023_02268_5
crossref_primary_10_1016_j_jece_2024_113523
crossref_primary_10_1016_j_cej_2022_136296
crossref_primary_10_1016_j_nantod_2021_101208
crossref_primary_10_1039_D0TB02138E
crossref_primary_10_3390_ma15196521
crossref_primary_10_1016_j_jclepro_2023_136479
crossref_primary_10_1021_acsami_2c07281
crossref_primary_10_1186_s40164_024_00525_3
crossref_primary_10_1002_smll_202007179
crossref_primary_10_1002_adma_202202609
crossref_primary_10_1016_j_apsadv_2025_100713
crossref_primary_10_3389_fphar_2022_832725
crossref_primary_10_1016_j_aca_2024_343004
crossref_primary_10_1016_j_ceramint_2021_09_108
crossref_primary_10_26896_1028_6861_2023_89_12_5_12
crossref_primary_10_1016_j_ceramint_2022_06_178
crossref_primary_10_1021_acsabm_2c00759
crossref_primary_10_1021_acsabm_3c00458
crossref_primary_10_1016_j_trac_2024_117801
crossref_primary_10_1016_j_jconrel_2022_06_050
crossref_primary_10_1039_D1CS01148K
crossref_primary_10_1039_D2TB01787C
crossref_primary_10_1007_s10238_023_01262_3
crossref_primary_10_51435_turkjac_1203081
crossref_primary_10_1016_j_jmgm_2024_108928
crossref_primary_10_3390_biomedicines12071500
crossref_primary_10_3390_molecules26144369
crossref_primary_10_1002_asia_202300477
crossref_primary_10_1039_D2RA03860A
ContentType Journal Article
Copyright The author(s).
2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The author(s) 2020
Copyright_xml – notice: The author(s).
– notice: 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The author(s) 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.7150/thno.45990
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic
Proquest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1838-7640
EndPage 10074
ExternalDocumentID PMC7481408
32929334
10_7150_thno_45990
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
53G
5VS
7X7
8FI
8FJ
AAYXX
ABUWG
ADBBV
ADRAZ
AENEX
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
DIK
FYUFA
GROUPED_DOAJ
HMCUK
HYE
KQ8
M48
M~E
O5R
O5S
OK1
PGMZT
PHGZM
PHGZT
PIMPY
RPM
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c472t-42fd46d44a16d5c159ec0671ecfcc810be42c744508d07a9a5b2fde7c4774cb13
IEDL.DBID M48
ISSN 1838-7640
IngestDate Thu Aug 21 14:12:19 EDT 2025
Thu Jul 10 22:51:17 EDT 2025
Mon Jun 30 10:55:32 EDT 2025
Mon Jul 21 05:39:10 EDT 2025
Tue Jul 01 04:04:03 EDT 2025
Thu Apr 24 22:53:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 22
Keywords combined cancer therapy
safety profile
Palladium-based nanomaterials
cancer imaging
photothermal therapy
Language English
License The author(s).
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c472t-42fd46d44a16d5c159ec0671ecfcc810be42c744508d07a9a5b2fde7c4774cb13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
These authors contributed equally to this work.
Competing Interests: The authors have declared that no competing interest exists.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.7150/thno.45990
PMID 32929334
PQID 2598245881
PQPubID 5263173
PageCount 18
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7481408
proquest_miscellaneous_2442848656
proquest_journals_2598245881
pubmed_primary_32929334
crossref_primary_10_7150_thno_45990
crossref_citationtrail_10_7150_thno_45990
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-01-01
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Wyoming
– name: Sydney
PublicationTitle Theranostics
PublicationTitleAlternate Theranostics
PublicationYear 2020
Publisher Ivyspring International Publisher Pty Ltd
Ivyspring International Publisher
Publisher_xml – name: Ivyspring International Publisher Pty Ltd
– name: Ivyspring International Publisher
SSID ssj0000402919
Score 2.5078247
SecondaryResourceType review_article
Snippet In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 10057
SubjectTerms Animals
Biocompatibility
Cancer therapies
Chemotherapy
Contrast agents
Contrast Media - administration & dosage
Copyright
Diagnostic Imaging - methods
Efficiency
Humans
Lasers
Morphology
Nanomaterials
Nanostructures - chemistry
Neoplasms - diagnostic imaging
Neoplasms - therapy
Palladium
Palladium - chemistry
Phototherapy - methods
Research Paper
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT9wwEB3xcWkPFeWjBGgVBBcOLok9iWMJCVVVEUKi6gGkvUWJ7RUrgUNh98C_ZybJhoVWnD1RopmJ3_PYfgNwWEhvFOGQ0GbsBKayEnWeO5FmVjHk1rnl0sDl7_z8Gi9G2agvuD32xyrnc2I7UbvGco38WLLSHF-rTE_v_wruGsW7q30LjWVYZekyzmo90kONhRJUmtR0qqSaqM_x9CY03zFrp-BFHPqHXL49I7kAOmdr8Klni_GPLryfYcmHdfi4oCG4ASd_uBTuJrM7wYjk4lCFhmhol1kxcdLYcmQf4sld25EoroKLu2tXT5twffbr6ue56FsiCItaTgXKscPcIVZp7jJLXMRbwpvU27G1RZrUHqXViES7XKIrU2U1PeE1Pa3R1qnagpXQBL8N8dho40yi6twl6ExWqMTmiuC-IE5BJC6Co7mDStvrhXPbituS1g3szJKdWbbOjOBgsL3vVDL-a7U393PZ_ymP5UtcI9gfhinHeeOiCr6ZkQ3SIgkLop4RfOnCMrxGSSJ4SmEE-lXABgPWz349EiY3rY62Rpb7Knbe_6xd-CB5jd2WXfZgZfow81-JiEzrb222PQPv2t8j
  priority: 102
  providerName: ProQuest
Title Palladium-based nanomaterials for cancer imaging and therapy
URI https://www.ncbi.nlm.nih.gov/pubmed/32929334
https://www.proquest.com/docview/2598245881
https://www.proquest.com/docview/2442848656
https://pubmed.ncbi.nlm.nih.gov/PMC7481408
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjZ3fS8MwEMcPnS_6IP62OkdFX3zIbJtr0oIgKooIioiDvZU2yXCgmc4N9L_30nbDqQ8-90LLXZr7XNp8D-AwiUzKKQ8xmfY0wzDKWSGEZmGsuEu5hVBua-D2Tlx38KYbd-dg0r-zduD7n6Wd6yfVGT63P94-T-mFJ35tS-KZ49GTHbQxpnV1HhYoI0nXyeC2xvxyRaYiKS17fNAETpgUGFRKpT-Gz-amX8D587_Jb4noagWWa4L0z6qQr8KcsWuw9E1XcB1O7t32uO6PX5jLUtq3uR0QmlazzSdO9ZWL9tDvv5Rdivzcar86ivW5AZ2ry8eLa1a3SWAKZTRiGPU0Co2Yh0LHivjEKMpBoVE9pZIwKAxGSiISiulA5mkeFzTCSBotURUh34SGHVizDX4vlalOA14IHaBO44QHSnBCgIQ4g8DOg6OJgzJVa4i7VhbPGdUSzpmZc2ZWOtODg6nta6Wc8adVc-LnbBL8LHKqgu4IbejB_vQyzXv3MSO3ZjAmG6TCCRPCUQ-2qrBMb8Mjgj7O0QM5E7CpgdPUnr1i-0-ltrZEJwGW7Pzr4XdhMXLld7kj04TGaDg2e8Qoo6IF87IrW7Bwfnl3_9Aqp-MXaf_oPg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V9gAcEOUZKMUIOHAwTWwnjiUQqlqqLX2IQyvtLU1sr7pS6_SxK9Q_1d_YmWQTtoC49ZxxEo3HM9-M7W8APuTCG4lxiGszclwlouRVljmepFZSyK0yS6WBvf1scKh-DNPhAlx3d2HoWGXnExtH7WpLNfI1QUxzdK0y-XZ2zqlrFO2udi00WrPY8Ve_MGW7_Lq9ifP7UYit7wcbAz7rKsCt0mLClRg5lTmlyiRzqcVw7i267MTbkbV5EldeCauVQuTiYl2aMq1whNc4WitbJRLfew-WMPDGlOzpoe5rOrgghElMy4KqEWqtTY5D_Vmljcufj3t_gdk_z2TOBbmtx_Bohk7ZemtOy7DgwxN4OMdZ-BS-_KTSuxtPTzlFQMdCGWqEva0lM8TAzJIlXbDxadMBiZXBsfaa19UzOLwTZT2HxVAH_xLYyGjjTCyrzMXKmTSXsc0kwoscVYmgMYJPnYIKO-MnpzYZJwXmKaTMgpRZNMqM4H0ve9aycvxTaqXTczFbmZfFbzuK4F3_GNcUbZSUwddTlFGYlKkcoW4EL9pp6T8jBQJKKVUE-taE9QLE1337SRgfN7zdWhG9WP7q_7_1Fu4PDvZ2i93t_Z3X8EBQft-UfFZgcXIx9W8QBE2q1cbyGBzdtanfALqvHIE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VrYToAfFNoIARcOBgNrGdOJZACGhXLYXVClGpt5DYjrpSm5R2V6h_jV_HTL7YAuLWc-wkGj973oztNwDPU-GNRD_EtSkdV5HIeZEkjkexleRyi8RSauDzNNnZVx8P4oM1-NnfhaFjlf2a2CzUrraUIx8LUpqja5XRuOyORcy2Jm9PvnOqIEU7rX05jRYie_78B4ZvZ292t3CsXwgx2f76YYd3FQa4VVosuBKlU4lTKo8SF1t07d7i8h15W1qbRmHhlbBaKWQxLtS5yeMCe3iNvbWyRSTxvVdgXVNUNIL199vT2Zchw4PTQ5jItJqoGonXeHFY1a9U3DiAVS_4F7X984Tmisub3IDrHVdl71pw3YQ1X92CjRUFw9vwekaJeDdfHnPyh45VeVUjCW5xzZARM0u4OmXz46YeEssrx9pLX-d3YP9SzHUXRlVd-fvASqONM6EsEhcqZ-JUhjaRSDZSZDRIIQN42Rsos51aORXNOMowaiFjZmTMrDFmAM-GtietRsc_W232ds66eXqW_UZVAE-HxzjDaNskr3y9xDYKQzSVIvEN4F47LMNnpEB6KaUKQF8YsKEBqXdffFLNDxsVb61IbCx98P_fegJXEebZp93p3kO4JijYb_I_mzBanC79I2REi-JxBz0G3y4b7b8AgmQiHA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Palladium-based+nanomaterials+for+cancer+imaging+and+therapy&rft.jtitle=Theranostics&rft.au=Liu%2C+Yongchun&rft.au=Li%2C+Jingchao&rft.au=Chen%2C+Mei&rft.au=Chen%2C+Xiaolan&rft.date=2020-01-01&rft.issn=1838-7640&rft.eissn=1838-7640&rft.volume=10&rft.issue=22&rft.spage=10057&rft.epage=10074&rft_id=info:doi/10.7150%2Fthno.45990&rft.externalDBID=n%2Fa&rft.externalDocID=10_7150_thno_45990
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1838-7640&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1838-7640&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1838-7640&client=summon